Catalyst Pharmaceuticals (CPRX) Gross Profit (2019 - 2025)
Historic Gross Profit for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to $125.7 million.
- Catalyst Pharmaceuticals' Gross Profit rose 1491.53% to $125.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.4 million, marking a year-over-year increase of 2463.15%. This contributed to the annual value of $422.9 million for FY2024, which is 2213.86% up from last year.
- Latest data reveals that Catalyst Pharmaceuticals reported Gross Profit of $125.7 million as of Q3 2025, which was up 1491.53% from $125.9 million recorded in Q2 2025.
- Over the past 5 years, Catalyst Pharmaceuticals' Gross Profit peaked at $125.9 million during Q2 2025, and registered a low of $25.5 million during Q1 2021.
- In the last 5 years, Catalyst Pharmaceuticals' Gross Profit had a median value of $86.0 million in 2024 and averaged $76.0 million.
- In the last 5 years, Catalyst Pharmaceuticals' Gross Profit soared by 215.32% in 2021 and then skyrocketed by 10274.74% in 2023.
- Quarter analysis of 5 years shows Catalyst Pharmaceuticals' Gross Profit stood at $31.0 million in 2021, then surged by 60.08% to $49.6 million in 2022, then skyrocketed by 91.19% to $94.8 million in 2023, then increased by 26.82% to $120.2 million in 2024, then rose by 4.63% to $125.7 million in 2025.
- Its Gross Profit stands at $125.7 million for Q3 2025, versus $125.9 million for Q2 2025 and $123.5 million for Q1 2025.